US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor
Patent 7851502 was granted and assigned to Bristol-Myers Squibb on December, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+190 characters)
Article
Patent abstract
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07851502 Pharmaceutical formulations containing an SGLT2 inhibitor US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor
Infobox
Patent Number
0785150200
Patent Number
785150200
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078515020
Date of Patent
December 14, 2010
0Patent Application Number
120534420
Date Filed
March 21, 2008
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078515020
Date of Patent
December 14, 2010
0Patent Application Number
120534420
Date Filed
March 21, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07851502 Pharmaceutical formulations containing an SGLT2 inhibitor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07851502
Date of patent
December 14, 2010
Patent application number
12053442
Date Filed
March 21, 2008
Patent primary examiner
Find more entities like US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
